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1. Introduction   
1.1 Tropane alkaloids: history and relevance 
Historically, plants have been the major source of active compounds for the pharmaceutical 
industry. Today, plant extracts and its active principles represent 25% of the annual 
commercialized drugs in the United States (Kinghorn and Seo, 1996, Buttler 2004, Prakash 
Rout et al., 2009, Qurishi et al., 2010). Moreover, the World Health Organization has 
estimated that more than the 80% of the population in developing countries relies for their 
health care on traditional medicines mostly from plant origin (Canter et al., 2005). The plant 
active principles are, in general, a product of the plant secondary metabolism; they are low-
molecular-weight compounds that in general participate in defence mechanisms against 
diseases (phytoalexins) or as attractants for pollinator insects (pigments and fragrances) 
(Canter et al., 2005). The production of each group of secondary metabolites, as counterpart 
of primary metabolites, is in general restricted to a limited number of species, and they 
usually are organ-specific and furthermore, tissue-specific. 
According to their chemical properties, secondary metabolites could be classified in three 
main groups: a) terpenes, b) phenols and c) alkaloids. Terpenes and terpenoids are the 
primary constituents of the essential oils, widely used as natural flavour additives for food 
and fragrances. Phenols are a class of chemical compounds consisting of a hydroxyl group 
directly bonded to an aromatic hydrocarbon group that seem to be universally distributed in 
plants. They are essential for the growth and reproduction of plants, and are produced as a 
response for defending injured plants against pathogens. Finally, alkaloids are characterized 
for being alkaline nitrogenated organic compounds, derived from aminoacids, generally 
insoluble in water and soluble in alcohol, ether, chloroform, etc. Among the alkaloids, those 
derived from tropane have received particular attention for their properties. 
1.2 Tropane alkaloids 
Tropane alkaloids are distributed among the plant families Orchidaceae, Dioscoreaceae, 
Proteaceae, Rhizophoraceae, Cruciferae, Eritroxilaceae, Euphorbiaceae, Convolvulaceae, Brassicaceae, 
Olacaceae and Solanaceae. Their principal characteristic is the presence of a pyrrolic ring 
derived from the ornintine and arginine aminoacids by a chemical reaction catalyzed by 
ornitin decarboxilase (ODC) and arginin decarboxilase (ADC) respectively (Figure 1). 
Ornithine and arginine also are the precursors of the polyamines putrescine, espermidine 
and espermine, which play a critical role in plant development by the regulation of the cell 
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division in plants (Theiss et al., 2002). On the other hand, putrescine, by the action of the 
enzyme putrescine N- methyltransferase (PMT; EC 2.1.1.53), is sequestered to the secondary 
metabolism being the first step of the tropane alkaloid biosynthetic pathway. 
 
 
Fig. 1. Primary metabolism precursors: arginine (A) and ornitine (B) and the tropane 
alkaloid final product scopolamine (C). 
Hyoscyamine and scopolamine are the end products of the tropane alkaloid biosynthetic 
pathway having both pharmacological applications for its action in the parasympathetic 
nervous system. Scopolamine, a 6,7-β-epoxide of hyoscyamine, is derived from 
hyoscyamine by the intermediate form 6β-hydroxyhyoscyamine (Fig. 2). The 
pharmaceutical industry employs hyosciamine, and its racemic form atropine, to obtain 
hyoscine N-butyl bromide that is used for its antispasmodic action since 1951. This 
semisynthetic derivative has pharmacological proprieties similar to those from scopolamine 
but with less activity and more adverse effects (Tytgat, 2007). Figure 2 compares the 
industrial process for producing the atropine racemic form of hyosciamine, and the 
scopolamine biosynthetic pathway in plants. 
1.2.1 Scopolamine 
Scopolamine is one of the earlier alkaloids purified from plant sources, described by Albert 
Ladenburg in 1880. It is the most valuable of the tropane alkaloids being its worldwide 
demand 10-fold the demand of the sum of hyosciamine (its precursor) and atropine (the 
semisynthetic drug) (Moyano et al., 2003). As atropine, scopolamine is an anticholinergic 
drug, besides it also has anti-muscarinic activity. Anticholinergic drugs are, in general, 
competitive and reversible inhibitors from acetylcholine with effects at parasympathetic 
level. Because of that pharmacological activity scopolamine has a number of uses in 
medicine. Its primary use is for the therapy of nausea (transdermal patchs), motion sickness 
and intestinal cramping. Also, it is used for ophtalmic purposes (to induce mydriasis and 
cycloplegia) and as a general depressant in combination with narcotic painkillers. It also has 
secondary uses are a preanesthetic agent, a drying agent for sinuses, lungs and related areas 
and to reduce motility and secretions in the gastrointestinal tract (tinctures). Uncommonly, 
it is also used for some forms of Parkinsonism, combined with opioids (e.g.: with morphine). 
The production and purification of scopolamine is extremely expensive which have made 
that several groups have focused in finding scopolamine analogs or synthetic forms.  
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Fig. 2. The racemic hyoscine N-butyl bromide is obtained from natural sources as 
hyoscyamine (A) or by semi-synthesis from atropine (B). Scopolamine is the final product in 
the tropane alkaloid pathway being hyoscyamine its precursor. 
1.2.3 Biosynthetic pathway, key points: PMT and H6H 
As was mentioned above, scopolamine and hyoscyamine are the most relevant tropane 
alkaloids widely in use. Their metabolic pathway starts in putrescine, a polyamine that is 
shared by several metabolic pathways (e.g.: pyridinic alkaloids). The role of putrescine 
methyl transferase (PMT; EC 2.1.1.53) is to sequester putrescine from the polyamine pool, 
which is the cross-point between the primary and secondary metabolism towards the 
tropane alkaloid pathway. The enzyme PMT catalyses the reaction from putrescine to N-
methyl putrescine with S-adenosyl methionine as methyl donor (Zhang et al., 2004, Stenzel 
et al., 2006). It was described by Mizusaki et al. (1973) in tobacco for the first time, 
afterwards it has also been described in Hyoscyamus sp. (Hashimoto et al., 1989, Suzuki et al., 
1999). The last part of the tropane alkaloid biosynthetic pathway is the enzymatic reaction 
catalyzed by hyoscyamine-6β-hidroxylase (H6H), a 2-oxoglutarate dependent dioxygenase 
(EC 1.14.11.11, MW: 41.000 ± 1.0, optimal pH 7.8) that catalyses the hydroxylation of 
hyoscyamine to scopolamine in two steps. The first step is the hydroxylation of 
hyoscyamine to 6-hydroxyhyoscyamine, a reaction that requires 2-oxoglutarate, Fe2+, 
molecular oxygen, and ascorbate. The second step is the epoxidation of the intermediate  
A 
B 
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6-hydroxyhyoscyamine producing the 6,7-- hyoscyamine epoxide (scopolamine) 
(Hashimoto and Yamada, 1986 and 1987).  
2. Strategies for scopolamine production 
The chemical complexity of tropane alkaloids turns almost impossible its substitution by 
other compounds or the de novo synthesis. To date, alkaloids are extracted from the 
macerated leaves of wild plants growing in greenhouses. The whole process, performed 
under Good Manufacture Practices (GMP), makes the final product very expensive thus the 
search of an alternative production strategy is a priority. The alternative methods comprise 
biotechnology approaches as the genetic transformation for metabolic engineering to 
overexpress the key proteins in the biosynthetic pathway and the establishment of in vitro 
organ, tissue and plant cultures from scopolamine producer species. 
2.1 Metabolic engineering 
The in-depth understanding of biosynthetic pathways, along with the increasing number of 
cloned genes involved in biosynthesis, enable the exploration of metabolic engineering as a 
potential effective approach to increase the yield of specific metabolites. It could be achieved 
by enhancing rate-limiting steps or by blocking competitive pathways. Metabolic 
engineering is a multidisciplinary powerful tool that uses from bioinformatics, genetics, 
biochemistry, systems biology, molecular biology, biochemical engineering, etc, for re-direct 
the metabolic flux generally in order to increase secondary metabolite production yields 
(e.g.: alkaloids). It also could be useful for a rational and directed modification of metabolic 
pathways to understand their design and regulation and to study the impact of 
intermediates and end products in a specific organism.  
When the improvement of a productive process is the main goal, the a priori knowledge of 
the metabolic pathway is fundamental. The next step is to know the kinetic of growth of the 
biomass that produces the product of interest, the parameters that could reflect that growth, 
and the election of the parameters that will led to the optimization of the process. Metabolic 
engineering uses different strategies such as improving the precursors production, re-
directing one or more enzymatic reactions in a metabolic pathway, widening the metabolic 
capacities by stress or increasing the enzymatic activities, etc. Also a reliable strategy is to 
direct the carbon flux towards the biosynthetic pathway by the overexpression of the genes 
codifying the limiting enzymes, blocking the feedback inhibition mechanism or the 
competitive pathways, diminishing catabolism, etc..  
2.1.1 Hairy root culture initiation and maintenance 
Hairy roots are obtained by infection of the plant with different Agrobacterium rhizogenes 
strains (e.g.: LBA9402 and LBA15834) that harbor the Ri vector (In: Agrobacterium-mediated 
genetic transformation: history and progress, present book). They are characterized by their 
indefinite and fast growth and its higher chromosomal stability than in vitro clonal 
multiplication. The first hairy root cultures were established at the end of the 1980’s 
(Oksman-Caldentey and Strauss, 1986, Hamill et al. 1987, Oksman-Caldentey et al., 1987). 
Since then, it has been established hairy roots from numerous species, among them 
scopolamine-producing species (Hyoscyamus, Brugmansia, Duboisia, Atropa, and Scopolia, etc). 
In general, hairy roots are initiated from axenic plants by infection with A. rhizogenes the 
hairy root tips usually appear in the infected areas approximately after one week of 
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infection, being a chimera between the infected and non-infected cells. Once initiated, they 
are maintained by transfer to selective media without the addition of plant growth 
regulators. The hairy root cultures are subcultured in the same medium approximately 
every 20 days. When the process is performed in liquid medium it is carried on under 
agitation in an orbital shaker (100 rpm) with 16 h- photoperiod using cool white fluorescent 
lamps. 
As we have said before, the synthesis of tropane alkaloids is produced in the pericycle of 
roots (Hashimoto et al., 1991) being the final products translocated to the aerial part of the 
plant. It is not surprising then that the establishment of hairy roots was considered as an 
alternative strategy for scopolamine production (Oksman-Caldentey et al., 1991, Oksman-
Caldentey and Arroo, 2000, Palazón et al., 2003 and 2008). It was reported that Datura 
stramonium hairy roots de-differentiated and loose their ability to synthesize scopolamine 
when treated with auxines (Palazón et al., 1995). On the other hand, undifferentiated 
cultures (calli) do not produce scopolamine proving the need of some degree of tissue 
specialization (Moyano et al., 1999; Jouhikainen et al., 1999). Evidently, the tropane alkaloid 
synthesis requires root organization when scopolamine is the end product.  
Even though hairy roots are scopolamine producers the yields achieved are low, which has 
fostered the quest of an alternative production strategy. In the 1990’s the first studies about 
the influence of plant growth regulators on scopolamine yields were performed. The effect 
of the addition of GA7 on kinetics of growth and alkaloid accumulation in two different 
Brugmansia candida hairy root clones have demonstrated that GA7 (10-4 to 10-1 mg.l-1) 
increased the scopolamine/hyoscyamine ratios in the early phases of growth, the sum of 
scopolamine plus hyoscyamine per flask decreased during the same growth period. Indeed 
the addition of GA3 produced higher growth rates but lower alkaloid concentration (Pitta 
Alvarez & Giulietti, 1997). 
2.1.2 Elicitation 
The term elicitor was first introduced to describe the action of biomolecules able to induce 
phytoalexin production. In general, elicitors induce defence systems and increase the 
resistance to pathogens in plants. Also, pathogens biomolecules derived from the pathogen 
cell wall (exogenous elicitors), and compounds released from plants by the action of the 
pathogen, triggers that defence response (Angelova et al., 2006). 
At the end of the 1990’s several groups started the study of the effect of elicitors on 
secondary metabolism. Hence, it was evident that biotic elicitors (produced by pathogenic 
microorganisms or released from their cell walls by plant enzymes) were able to induce 
changes in secondary metabolites patterns. Also, the release of certain compounds, such as 
cellulose or pectinase and molecules active in the signal transduction pathway (salicylic 
acid, jasmonic acid), could also promote the plant defence response (Benhamou, 1996; Guo 
et al., 1997; Lawrence et al., 2000). That response includes the production of phytoalexins 
(pathogeneses related proteins), protease inhibitors and a variety of other defence 
compounds (among them alkaloids). In vitro plant cell cultures have been used for studying 
the influence of elicitors on secondary metabolism (Zabetakis et al., 1998, Jung et al., 2003, 
Marconi et al., 2008), and also their influence on tropane alkaloid metabolism particularly in 
hairy roots (Pitta Alvarez et al., 2000, 2001, Ajungla et al., 2009). Non-conventional elicitors 
(e.g.: acetate buffer, pectinase, Hormonema sp. homogenate), increased intracellular 
hyoscyamine content (200-300%), and the release of scopolamine (up to 1500%) and 
hyosciamine (up to 1100%) in B. candida hairy roots (Pitta-Alvarez et al., 2003). Thus, elicitors 
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represent a promising and inexpensive alternative to increase production of hyoscyamine 
and scopolamine by in vitro culture. 
3. Metabolic and genetic engineering 
Molecular biology, as a tool for DNA manipulation, could be used for engineering metabolic 
pathways. Figure 3 shows the usual strategies employed for overproducing a specific 
metabolite (C ). 
 
 
Fig. 3. Strategies for increasing secondary metabolite production by engineering 
metabolism. 
The strategies metabolic engineering uses to increase secondary metabolite production are 
a) the overexpression of secondary metabolite precursors (A); b) the overexpression of genes 
whose products are rate-limiting (B), c) the creation of new branches in the biosynthetic 
pathway (E to C), d) the blocking of reactions (C to D) redirecting them to the C pathway, 
among others. Also, there are other strategies for overproducing C such as a) manipulation 
of regulatory genes, b) a positive or negative regulation of gene expression, c) selection of 
mutants with increased expression of metabolites, d) use of specific promoters for 
tissue/organ specific expression, e) iRNA technology and gene silencing. Each of the 
strategies above mentioned has unpredictable consequences in the cell homeostasis.  
3.1 Overexpression of key enzymes 
Overexpression of a key enzyme in the biosynthetic pathway is one of the strategies used to 
increase secondary metabolite production. In general, the overexpressed enzyme catalyzes a 
bottleneck step. In the tropane alkaloid pathway the key enzyme is H6H. As was mentioned 
above, H6H catalyzes two reactions, the hydroxylation at position 6, rendering an 
intermediate 6-hydroxyhyoscyamine; and the epoxidation that leads to the end product 
scopolamine. Therefore, overexpression of H6H is an attractive strategy for poor 
scopolamine producing species with hyoscyamin-rich accumulation. In vitro shoot and 
callus cultures shown very low concentration of H6H and, hence, scopolamine production. 
On the contrary, hairy root cultures from scopolamine-producing species have high 
concentration of H6H. The difference in the expression of this enzyme could be attributed to 
the specialization of root pericycle for producing H6H. Several attempts were made in order 
to isolate and overexpress the H6H cDNA in hairy roots for scopolamine production. The 
h6h cDNA was isolated from B. candida, H. muticus, A. belladonna, Duboisia hybrid with high 
producing scopolamine capacity (Matsuda et al., 1991, Jouhikainen et al., 1999, Cardillo et 
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al., 2005; Canter et al., 2005, Oksman-Caldentey et al., 2007, Palazón et al., 2008). All the 
isolated sequences reveled high homology (>80%). A strategy used is to introduce in low-
producing scopolamine species numerous copies of their own H6H gene. All the protocols 
have several common steps. First, the h6h cDNA is cloned into the binary vector and 
amplified in Escherichia coli. Then, A. rhizogenes is transformed with the binary vector 
obtained and used for re-introducing, by agrotransformation, that h6h cDNA into the 
genome of the same species from which it was isolated. However, the results were not 
successful because the H6H overexpressing clones obtained did not have a significant 
increase on alkaloid production. Those results could be attributed to an upstream regulation 
of alkaloid biosynthesis, to a rate limiting speed of H6H or to a deficiency of precursors.  
Another strategy focus on the lack of substrates in the tropane alkaloid pathway. Thus, the 
carbon flux is redirect from the primary to the secondary metabolism, being PMT the key 
and pivot enzyme between both metabolisms. There is a strong expression of the pmt gene 
in the pericycle of Atropa belladona roots that is suppressed by the addition of exogenous 
auxins (Suzuki et al., 1999, Hibi et al., 1994, Palazón et al., 1995). There are several protocols 
describing the establishment of PMT overexpressing hairy roots. Nevertheless the results 
obtained are as disappointing as those obtained overexpressing H6H. The first report of 
PMT overexpression in hairy roots was with Hyoscyamus albus (Hashimoto et al., 1989). 
Tracer-feeding studies with radioactive aminoacids demonstrated that putrescine is the 
precursor of tropane alkaloids. Sato et al. (2000) have reported the overexpression of PMT in 
Atropa belladonna hairy roots revealing an increase in polyamines pools. However, the 
alkaloid profile remained unchangeable. On the other hand, the overexpression of PMT 
from Nicotiana tabacum in Duboisia hybrid hairy roots (yielding scopolamine) produced an 
increase of pmt gene expression that is not reflected in the alkaloid production (Moyano et 
al. 2000). Also, there are reports of heterologous tests with non-tropane alkaloid producing 
species such as Solanum tuberosum (Stenzel et al., 2006) and Nicotiana sylvestris (Sato et al., 
2001). The overexpression of PMT in N. sylvestris increasead the nicotine concentration, 
probably for a higher metabolic flux towards the tropane and pyridinic alkaloid pathways. 
However, when the pmt gene was overexpressed in the tropane alkaloid producer A. 
belladonna (Sato el al., 2001) and the Duboisia hybrid (Moyano et al., 2002), no significant 
increase in scopolamine was observed suggesting that methylputrescine is not the rate 
limiting substrate in the tropane alkaloid pathway. 
The overexpression of only one enzyme in a complex metabolic net could not be sufficient to 
increase some secondary metabolite expression. Particularly, there are several works about 
the overexpression of more than one of the enzymes involved in the alkaloid tropane 
pathway (Zhang et al., 2004, Liu et al., 2010, Chunxian et al., 2011). However, not significant 
scopolamine yields were attained. The unsuccessful results could be attributed to the 
transgenic transformation processes itself. The mechanism of integration of transgenes into 
plant DNA is poorly understood, the integration of many genes at one or a few loci could 
not happen by chance. Also, multiple copies of one or more transgenes can result in 
postranscriptional gene silencing and turn unstable and reduce gene expression (Matzke & 
Matzke; 1998; Palazón et al., 1998; Bulgakov et al., 2004; Kutty et al., 2011). Evidently, h6h 
played a more important role in stimulating scopolamine accumulation than pmt. 
Nevertheless, when pmt redirects the carbon flux to the tropane pathway and h6h is 
overexpressed there is an accumulation of scopolamine (Zhang et al. 2004). 
The genetic transformation with numerous in-tandem genes could be troublesome. For 
hairy root induction and pmt and h6h cDNA insertion, at least three tandem transformations  
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Fig. 4. Scheme of the site-specific recombination between the PCR product harboring pmt or 
h6h cDNA and the binary vector. During the first PCR round (PCR 1st Reaction), the H6H 
(or PMT) cDNA is isolated and purified from an agarose gel electrophoresis (A). The PCR 
fragment is inserted between the specific attachment sites sequences (att sites) into the Entry 
pCR8/FW/TOPO vector producing the plasmid pCR+H6H (B). The second round of PCR 
(PCR 2nd Reaction) is carried out with the M13 forward and reverse primers in order to 
amplify a cDNA fragment encoding the sequence of interest flanked by the att left and right 
recombination sequences. These sequences permit the site-specific recombination between 
the extended PCR fragments and a Destination binary plasmid (pK7WG2.00) following the 
Gateway protocol. LR Clonase II enzyme MIX is used to catalyze the site specific 
recombination reaction which is performed according to the manufacturer’s protocol 
(Invitrogen). The final product is the binary destination vector pK7+H6H (C).  
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are needed. New and simple DNA transfer methods simplify the process as, for example, 
the Gateway system, based on bacteriophague Lambda site-specific recombination system 
(Karimi et al., 2002; Attanasov et al., 2009; Dubin et al., 2008, Xu & Quinn, 2008). Figure 4 
shows a protocol designed in our lab for the production of a PCR fragment for h6h cDNA 
ready to recombine into the destination vector independently of the antibiotic gene 
resistance. 
4. New approaches 
In this chapter, we have reviewed some of the most relevant strategies for improving 
tropane alkaloid biosynthesis such as the establishment of scopolamine overproducing 
organ cultures, the elicitation and the genetic transformation with homologous genes. 
Nevertheless, the knowledge generated and the strategies in use have demonstrated that the 
tropane alkaloid metabolism is immersed into a complex net of metabolic pathways with a 
delicate equilibrium quite difficult to be manipulated. Modern system biology tools, like 
elicitation and overexpression, allow the carbon flux redirection with some limitations. 
These margins cannot be overcome and decelerate the development of a competitive and 
sustainable production platform. Those troubles and limitations have fostered new 
strategies based on functional genomics (Goossens et al., 2002; Goossens & Rischer, 2007, 
Oksman-Caldentey & Inzé, 2004) such as biotransformation. 
Biotransformation is one of those new strategies. The production of scopolamine and other 
alkaloids was studied in engineered N. tabacum hairy roots overexpressing the h6h cDNA 
after feeding the cultures with exogenous hyoscyamine (Hakkinen et al., 2005). The results 
obtained have shown an efficient uptake of hyoscyamine from the culture medium and a 
higher rate of bioconversion of hyoscyamine to scopolamine (up to 85% of the total 
scopolamine being released to the culture medium). Moreover, it was also evident an 
enhanced production of various nicotine alkaloids suggesting that the regulation of the 
alkaloid production is probably more complex than presently known.  
Another approach was the bioconversion of hyoscyamine to scopolamine using 
recombinant Saccharomyces cerevisiae that expresses the h6h cDNA isolated from B. candida as 
a biocatalyzer. Transformed S. cerevisiae CEM PK2 expressing H6H as heterologous protein 
was able to grow into yeast base medium supplemented with hyoscyamine. However, the 
results have shown a low ability of hyoscyamine conversion to scopolamine (Cardillo et al., 
2005 and 2008). 
5. Conclusions 
In the last two decades plant biotechnology has made considerable advances in the quest of 
a scopolamine and other tropane alkaloids productive process. Several groups have 
explored a wide spectrum of strategies that have led to the exhaustive knowledge of the 
tropane alkaloid pathway, its limiting steps and some of the regulation pathways. It is 
evident that genetic transformation is a promissory tool for engineering tropane alkaloid 
biosynthetic metabolism in order to produce high amounts of scopolamine. Combining 
genetic transformation and metabolic engineering would be a powerful strategy to re-direct 
the metabolic flux towards that biosynthetic pathway. It became clear, from the results 
already published, that the overexpression of pmt gene and/or h6h gene not only stimulated 
the conversion of hyoscyamine to scopolamine, but also the capacity of these hairy root lines 
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to synthesize both tropane alkaloids. However, the yields obtained up to now did not reach 
those of the current scopolamine productive process. Future research could be done 
considering the higher structural diversity of tropane alkaloids that could be functional to 
create new metabolic pathways and biological active products. A possible strategy would be 
cloning and engineering those new metabolic pathways in heterologous organism to 
produce a chemical structure diversity for generating new compounds with scopolamine-
like activity (Harvey, 2000, Butler, 2004, Potterat & Hamburger, 2008). 
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